Skip to main content
. 2024 Apr 18;19(4):e0295986. doi: 10.1371/journal.pone.0295986

Table 1. Baseline characteristics of participants.

Characteristic NAFLD P-value
No Yes
N 5222 4221
Demographics
Age (year), Median (Q1-Q3) 47.50 (33.00–64.00) 53.00 (39.00–65.00) <0.001
Sex <0.001
Male 2250 (43.09%) 2136 (50.60%)
Female 2972 (56.91%) 2085 (49.40%)
Race <0.001
Mexican American 662 (12.68%) 750 (17.77%)
Other Hispanic 538 (10.30%) 437 (10.35%)
Non-Hispanic White 2261 (43.30%) 1941 (45.98%)
Non-Hispanic Black 979 (18.75%) 818 (19.38%)
Other Race—Including Multi-Racial 782 (14.98%) 275 (6.52%)
Education level <0.001
<High school 1048 (20.07%) 1079 (25.56%)
High school 1109 (21.24%) 1013 (24.00%)
>High school 3065 (58.69%) 2129 (50.44%)
Ratio of family income to poverty <0.001
< = 1 1020 (19.53%) 927 (21.96%)
1–3 2146 (41.10%) 1927 (45.65%)
>3 2056 (39.37%) 1367 (32.39%)
Behavioral Characteristics
Smoking status <0.001
Never 3239 (62.03%) 2257 (53.47%)
Now 879 (16.83%) 734 (17.39%)
Former 1104 (21.14%) 1230 (29.14%)
Work activities status 0.022
No 3085 (59.08%) 2362 (55.96%)
Vigorous 186 (3.56%) 164 (3.89%)
Moderate 1180 (22.60%) 1011 (23.95%)
Both 771 (14.76%) 684 (16.20%)
Recreational activities status <0.001
No 2359 (45.17%) 2499 (59.20%)
Vigorous 475 (9.10%) 217 (5.14%)
Moderate 1483 (28.40%) 1091 (25.85%)
Both 905 (17.33%) 414 (9.81%)
Dietary Characteristics
Dietary energy intake (kcal), Median (Q1-Q3) 3659.50 (2844.25–4737.00) 3779.00 (2879.00–4814.00) 0.029
Dietary protein intake (g),Median (Q1-Q3) 143.91 (109.73–188.50) 149.50 (111.44–194.87) 0.001
Dietary alcohol intake (g), Mean ± SD 5.28 ± 11.90 4.49 ± 11.55 0.001
Dietary vitamin C intake (mg), Median (Q1-Q3) 134.70 (66.20–236.40) 115.00 (54.50–213.30) <0.001
Related disease conditions
Hypertension status <0.001
No 3489 (66.81%) 1860 (44.07%)
Yes 1733 (33.19%) 2361 (55.93%)
Diabetes status <0.001
No 3813 (73.02%) 1874 (44.40%)
Yes 639 (12.24%) 1440 (34.12%)
IFG 392 (7.51%) 538 (12.75%)
IGT 378 (7.24%) 369 (8.74%)
Anthropometric measurements
Waist Circumference (cm), Mean ± SD 89.20 ± 9.65 113.49 ± 13.08 <0.001
BMI (kg/m^2), Mean± SD 25.09 ± 3.57 34.73 ± 6.27 <0.001
Biochemical indicators
Uric Acid (mg/dl), Mean± SD 5.05 ± 1.27 5.98 ± 1.42 <0.001
Fasting Glucose (mg/dl), Mean± SD 102.24 ± 25.53 119.85 ± 43.50 <0.001
Glycohemoglobin (%), Mean± SD 5.57 ± 0.82 6.09 ± 1.32 <0.001
Creatinine (mg/dL), Median (Q1-Q3) 0.82 (0.69–0.98) 0.85 (0.72–1.02) <0.001
GGT (IU/L), Median (Q1-Q3) 16.00 (12.00–22.00) 25.00 (18.00–39.00) <0.001
Triglycerides (mg/dL), Median (Q1-Q3) 82.00 (60.00–113.00) 136.00 (96.00–192.00) <0.001
Total cholesterol (mg/dL), Mean ± SD 187.71 ± 39.83 195.54 ± 42.19 <0.001
HDL cholesterol (mg/dL), Mean ± SD 58.05 ± 15.45 46.82 ± 12.13 <0.001
AST (u/l), Median (Q1-Q3) 22.00 (19.00–26.00) 23.00 (19.00–28.00) <0.001
ALT(u/l), Median (Q1-Q3) 18.00 (15.00–24.00) 23.00 (18.00–32.00) <0.001
Total Protein (g/dl), Mean ± SD 7.14 ± 0.45 7.15 ± 0.45 0.12
Globulin (g/dl), Mean ± SD 2.88 ± 0.44 3.01 ± 0.46 <0.001
Total Bilirubin (mg/dl), Median (Q1-Q3) 0.70 (0.50–0.90) 0.60 (0.50–0.80) <0.001

Abbreviations: CDAI, Composite Dietary Antioxidant Index; NAFLD, Nonalcoholic Fatty Liver Disease; IFG, Impaired Fasting Glycemia; IGT, Impaired Glucose Tolerance; BMI, Body Mass Index; GGT, Gamma glutamyl transferase; AST, Aspartate Transaminase; ALT, Alanine Aminotransferase

*BMI was calculated as the body weight in kilograms divided by the square of the height in meters

P value: if it is a continuous variable, it is obtained by Kruskal Wallis rank sum test. If the theoretical number of counting variables is less than 10, it is obtained by Fisher exact probability test.